Abstract
THE ras genes are required for normal cell growth and mediate transformation by oncogenes encoding protein tyrosine kinases1,2. Normal ras can transform cells in vitro and in vivo, but mutationally activated ras does so much more efficiently, and highly transforming mutant versions of ras have been isolated from a variety of human and animal tumours (reviewed in refs 3–5). The ras genes encode membrane-associated, guanine nucleotide-binding proteins that are active when GTP is bound and inactive when GDP is bound6–8. The slow intrinsic GTPase activity of normal mammalian Ras proteins can be greatly accelerated by the GTPase-activating protein (GAP), which is predominantly cytoplasmic. This activity of GAP, which can increase with cell density in contact-inhibited cells9, suggests that it functions as a negative, upstream regulator of ras. Other studies10,11, however, show that GAP interacts with a region of ras-encoded protein implicated in ras effector function12,13, which raises the possibility that GAP might also be a downstream target of ras (reviewed in ref. 14). Mutationally activated ras-encoded proteins also interact with GAP15, although they are resistant to its catalytic activity7. In an attempt to define the role of GAP in ras-mediated transformation, we examined the effects on transformation of normal or mutant ras when cells overexpress GAP. We found that GAP suppresses transformation of NIH 3T3 cells by normal Ha-ras (c-ras) but does not inhibit transformation by activated Ha-ras (v-ras). These results support the hypothesis that GAP functions as a negative regulator of normal ras and make it unlikely that GAP alone is the ras target.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mulcahy, L. S., Smith, M. R. & Stacey, D. W. Nature 313, 241–243 (1985).
Smith, M. R., DeGudicibus, S. J. & Stacey, D. W. Nature 320, 540–543 (1986).
Barbacid, M. Ann. Rev. Biochem. 56, 779–827 (1987).
Gibbs, J. B. & Marshall, M. S. Microbiol. Rev. 53, 171–185 (1989).
Velu, T. J., Vass, V. C., Lowy, D. R. & Tambourin, P. E. J. Virol. 63, 1384–1392 (1989).
Field, J., Broek, D., Kataoka, T. & Wiglet, M. Molec. cell. Biol. 7, 2128–2133 (1987).
Trahey, M. & McCormick, F. Science 238, 542–545 (1987).
Satoh, T., Nakamura, S. & Kaziro, Y. Molec. cell. Biol. 7, 4553–4556 (1987).
Hoshino, M., Kawakita, M. & Hattori, S. Molec. cell. Biol. 8, 4169–4173 (1988).
Adari, H., Lowy, D. R., Willumsen, B. M., Der, C. J. & McCormick, F. Science 240, 518–521 (1988).
Calės, C., Hancock, J. F., Marshall, C. & Hall, A. Nature 332, 548–551 (1988).
Sigal, I. S., Gibbs, J. B., D'Alonzo, J. S. & Scolnick, E. M. Proc. natn. Acad. Sci. U.S.A. 83, 4725–4729 (1986).
Willumsen, B. M. et al. Molec. cell. Biol. 9, 2646–2654 (1986).
McCormick, F. Cell 56, 5–8 (1989).
Vogel, U. S. et al. Nature 335, 90–93 (1988).
Trahey, M. et al. Science 242, 1697–1700 (1988).
Jhappan, C., Vande Woude, G. P. & Robins, T. J. Virol. 60, 750–753 (1986).
Stone, J. C., Vass, W. C., Willumsen, B. M. & Lowy, D. R. Molec. cell. Biol. 8, 3565–3569 (1988).
Blair, D. G., McClements, W. L., Oskersson, M. K., Fischinger, P. J. & Vande Woude, G. F. Proc. natn. Acad. Sci. U.S.A. 77, 3504–3508 (1980).
Hartman, S. C. & Mulligan, R. C. Proc. natn. Acad. Sci. U.S.A. 85, 8047–8051 (1988).
Molloy, C. J. et al. Nature 342, 711–714 (1989).
Marshall, M. S. et al. EMBO J. 8, 1105–1110 (1989).
Ballester, R. et al. Cell 59, 681–686 (1989).
Tanaka, K. et al. Cell 60, 803–807 (1990).
Field, J. et al. Molec. cell. Biol. 8, 2159–2165 (1988).
Beckner, S. K., Hattori, S. & Shih, T. Y. Nature 317, 71–73 (1985).
Levitzki, A., Rudick, J., Pastan, I., Vass, W. C. & Lowy, D. R. FEBS Lett. 197, 134–138 (1986).
Ellis, C., Moran, M., McCormick, F. & Pawson, T. Nature 343, 377–381 (1990).
Feldman, R. A., Lowy, D. R., Vass, W. C. & Velu, T. J. J. Virol. 63, 5469–5474 (1989).
Dhruva, B. R., Shenk, T. & Subramanian, K. N. Proc. Acad. Sci. U.S.A. 77, 4514–4518 (1980).
Smith, P. K. et al. Analyt. Biochem. 150, 76–85 (1985).
Furth, M. E., Davis, L. J., Fleurdelys, B. & Scolnick, E. M. J. Virol. 43, 294–304 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, K., DeClue, J., Vass, W. et al. Suppression of c-ras transformation by GTPase-activating protein. Nature 346, 754–756 (1990). https://doi.org/10.1038/346754a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/346754a0
This article is cited by
-
p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities
Oncogene (2009)
-
The Ras signal transduction pathway
Cancer and Metastasis Reviews (1994)
-
Signal transduction pathways involving the raf proto-oncogene
Cancer and Metastasis Reviews (1994)
-
Investigation of the mechanism underlying the inhibitory effect of heterologous ras genes in plant cells
Plant Molecular Biology (1993)
-
Non–Neutralizing Monoclonal Antibodies Against RAS GTPase–Activating Protein: Production, Characterization and Use in an Enzyme Immunometric Assay
Nature Biotechnology (1992)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
